Dr. William Haseltine receives the 2023 IHV Lifetime Achievement Award
ACCESS Health International Chair and CEO, Dr. William Haseltine recently received the 2023 Institute of Human Virology 25th Anniversary Lifetime Achievement Award for Scientific Contributions and Drug Development. Prior to founding ACCESS Health International. Dr. Haseltine helped create the biotechnology companies ProScript …
Dr. Krishna Reddy Designated President of ACCESS Health International Asia
After the success of collaborations such as the Fintech for Health program and the GLC4SR, we are pleased to announce that the Board of ACCESS Health International has recommended merging its operations across Asia and designating Dr. Krishna Reddy Nallamalla, the current …
Reimagining Alzheimer’s (Part 7): Cholesterol Abnormalities May Contribute To Alzheimer’s Disease
This article is the seventh installment in my series on Alzheimer’s disease. Read more about Alzheimer’s disease in part 1, part 2, part 3, part 4 , part 5, and part 6 of the series. An Introduction to APOE4 A recent study published in Nature provides new insights into genetic predispositions to …
Reimagining Alzheimer’s (Part 6): The Many Effects Of The APOE4 Variant
This article is the sixth installment in my series on Alzheimer’s disease. Read more about Alzheimer’s disease in part 1, part 2, part 3, part 4 , and part 5 of the series. A recent paper published in the journal Nature has revealed a new mechanism by which …
Reimagining Alzheimer’s (Part 5): Setback For Potential Alzheimer’s Treatment
This article is the fifth installment in my series on Alzheimer’s disease. Read more about Alzheimer’s disease in part 1, part 2, part 3, and part 4 of the series. In the last installment of my series on Alzheimer’s disease, I discussed a new experimental …
Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment
This article is the fourth installment in my series on Alzheimer’s disease. Read more about Alzheimer’s disease in part 1, part 2, and part 3 of the series. The pharmaceutical and biotech companies, Eisai and Biogen recently revealed promising clinical trial results …
Reimagining Alzheimer’s (Part 2): Breaking The Barrier
In the first installment of this series about Alzheimer’s disease, we discussed a general overview of Alzheimer’s along with its most well-known biological indicators. Here, we take a deeper dive into the disease by focusing on a recent paper that explores the primary genetic …
Reimagining Alzheimer’s (Part 1)
Alzheimer’s disease affects over 5 million individuals in the United States and has proven to be an enigma in the scientific world. Historically, scientists have believed that Alzheimer’s disease was solely caused by two dysfunctional proteins in the brain called ß-amyloid and tau. …
Research On Flies Provides Hope For Brain Repair
This story on neuro-regeneration is part of an extended series on Regenerative Medicine. For other stories on this topic see williamhaseltine.com and search for Regenerative Medicine. My definition of Regenerative Medicine is any medical modality that returns us to normal health when we are damaged by …
Statement on Roe v. Wade Supreme Court decision
ACCESS Health International believes in the right to access high-quality healthcare for all people to live healthy and productive lives. Restricting access to safe and legal abortion services significantly jeopardizes a person’s physical and mental health. In the US, a 1973 court …
Recent Comments